Priscilla A Hollander

Summary

Affiliation: Baylor University Medical Center
Country: USA

Publications

  1. doi request reprint Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T-emerge 7 study)
    Priscilla Hollander
    Endocrinology Center, Baylor Medical Center, Dallas, Texas, USA
    Obesity (Silver Spring) 21:238-47. 2013
  2. doi request reprint Controversies in prediabetes: do we have a diagnosis?
    Priscilla Hollander
    Baylor Endocrine Center, Dallas, TX 75246, USA
    Postgrad Med 124:109-18. 2012
  3. doi request reprint Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial
    P Hollander
    Baylor Endocrine Center, Baylor University Medical Center, Dallas, TX, USA
    Diabetes Obes Metab 13:268-75. 2011
  4. doi request reprint Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes
    Priscilla A Hollander
    Baylor University Medical Center, Dallas, Texas 75246, USA
    Diabetes Technol Ther 12:185-91. 2010
  5. pmc Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial
    Priscilla A Hollander
    Baylor University Medical Center, Dallas, Texas, USA
    Diabetes Care 33:605-7. 2010
  6. doi request reprint Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone
    Priscilla Hollander
    Baylor University Medical Center, Department of Endocrinology, 3600 Gaston Avenue, Wadley 656, Dallas, Texas 75246, USA
    J Clin Endocrinol Metab 94:4810-9. 2009
  7. doi request reprint A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes
    Priscilla Hollander
    Baylor Medical Center Dallas, Texas 75246, USA
    Clin Ther 30:1976-87. 2008
  8. ncbi request reprint Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes
    Priscilla Hollander
    Endocrinology Center, Baylor University Medical Center, 3600 Gaston Way, Wadley Tower, Dallas, TX 75246, USA
    Arch Intern Med 167:1284-90. 2007
  9. ncbi request reprint Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials
    Priscilla A Hollander
    Baylor Endocrine Center, Baylor University Medical Center, Dallas, TX 75246, USA
    Diabetes Care 30:2508-10. 2007
  10. pmc Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes
    Priscilla A Hollander
    Baylor University Medical Center, Endocrinology Center, Dallas, Texas, USA
    MedGenMed 9:45. 2007

Detail Information

Publications16

  1. doi request reprint Effects of taspoglutide on glycemic control and body weight in obese patients with type 2 diabetes (T-emerge 7 study)
    Priscilla Hollander
    Endocrinology Center, Baylor Medical Center, Dallas, Texas, USA
    Obesity (Silver Spring) 21:238-47. 2013
    ..This study assessed the efficacy of taspoglutide compared with placebo on glycemic control and weight in obese patients with T2DM inadequately controlled with metformin monotherapy...
  2. doi request reprint Controversies in prediabetes: do we have a diagnosis?
    Priscilla Hollander
    Baylor Endocrine Center, Dallas, TX 75246, USA
    Postgrad Med 124:109-18. 2012
    ..These results, and the varying guidelines for the diagnosis of prediabetes, suggest a need for informed scientific debate on diagnostic criteria and recommendations for preventive care of prediabetic states...
  3. doi request reprint Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial
    P Hollander
    Baylor Endocrine Center, Baylor University Medical Center, Dallas, TX, USA
    Diabetes Obes Metab 13:268-75. 2011
    ....
  4. doi request reprint Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes
    Priscilla A Hollander
    Baylor University Medical Center, Dallas, Texas 75246, USA
    Diabetes Technol Ther 12:185-91. 2010
    ..New York, NY] [insulin human (recombinant DNA origin)] inhalation powder) in patients with type 2 diabetes inadequately controlled on combination oral antidiabetes agents (OADs)...
  5. pmc Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial
    Priscilla A Hollander
    Baylor University Medical Center, Dallas, Texas, USA
    Diabetes Care 33:605-7. 2010
    ..0001). Hypoglycemia, nausea, dizziness, anxiety, and depression were more frequent with rimonabant. CONCLUSIONS Rimonabant improved glycemic control and cardiometabolic risk factors in patients with type 2 diabetes receiving insulin...
  6. doi request reprint Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone
    Priscilla Hollander
    Baylor University Medical Center, Department of Endocrinology, 3600 Gaston Avenue, Wadley 656, Dallas, Texas 75246, USA
    J Clin Endocrinol Metab 94:4810-9. 2009
    ..Due to the natural progression of type 2 diabetes (T2D), most patients require combination therapy to maintain glycemic control...
  7. doi request reprint A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes
    Priscilla Hollander
    Baylor Medical Center Dallas, Texas 75246, USA
    Clin Ther 30:1976-87. 2008
    ....
  8. ncbi request reprint Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes
    Priscilla Hollander
    Endocrinology Center, Baylor University Medical Center, 3600 Gaston Way, Wadley Tower, Dallas, TX 75246, USA
    Arch Intern Med 167:1284-90. 2007
    ....
  9. ncbi request reprint Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials
    Priscilla A Hollander
    Baylor Endocrine Center, Baylor University Medical Center, Dallas, TX 75246, USA
    Diabetes Care 30:2508-10. 2007
  10. pmc Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes
    Priscilla A Hollander
    Baylor University Medical Center, Endocrinology Center, Dallas, Texas, USA
    MedGenMed 9:45. 2007
    ..Taken together, these findings suggest that INH represents an important new development in the treatment of diabetes that may improve glycemic control in many patients with diabetes...
  11. ncbi request reprint Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus
    Priscilla Hollander
    Ruth Collins Diabetes Center, Baylor University Medical Center at Dallas, Dallas, Texas 75246, USA
    Am J Med 120:S18-28; discussion S29-32. 2007
    ..Its multifactorial mechanisms warrant further investigation and may provide insights into other pathologies...
  12. ncbi request reprint Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial
    Priscilla A Hollander
    Baylor University Medical Center, Endocrinology Center, 3600 Gaston Ave, Wadley Tower, Dallas, TX 75246, USA
    Diabetes Care 27:2356-62. 2004
    ....
  13. pmc Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes
    Julio Rosenstock
    Dallas Diabetes and Endocrine Center, Dallas, Texas, USA
    Diabetes Care 31:1723-8. 2008
    ..The purpose of this study was to evaluate the 2-year pulmonary safety of inhaled human insulin (Exubera [EXU]) in 635 nonsmoking adults with type 2 diabetes...
  14. ncbi request reprint Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial
    Priscilla A Hollander
    Baylor University Medical Center, Dallas, Texas, USA
    Diabetes Care 26:784-90. 2003
    ..The aim of the present study was to assess the long-term efficacy and safety of pramlintide in this patient population...
  15. doi request reprint Type 2 diabetes comorbidities and treatment challenges: rationale for DPP-4 inhibitors
    Priscilla A Hollander
    Baylor University Medical Center, Dallas, TX, USA
    Postgrad Med 122:71-80. 2010
    ....
  16. ncbi request reprint Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs
    Philip Raskin
    Department of Internal Medicine, Southwestern Medical Center at Dallas, Dallas, TX 75390 8858, USA
    Diabetes Care 28:260-5. 2005
    ..Safety and efficacy of biphasic insulin aspart 70/30 (BIAsp 70/30, prebreakfast and presupper) were compared with once-daily insulin glargine in type 2 diabetic subjects inadequately controlled on oral antidiabetic drugs (OADs)...